Replies to post #12469 on FDA Plays

[trade2much]

NEOP was just given a price target of $6 within the last couple of days, and we seem to have a number of events on the horizon, plus institutional visibility due to the AMEX listing we just got. I think one should do very well in 2011 and all things associated with oncology are always interesting to the market. So we shall see but I think it has a bright future. jmho Course a profit is the objective for us so you obviously accomplish that, KUDOS